Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

European Ankylosing Spondylitis Infliximab Cohort (EASIC) Follow up Registration Study

NCT01286545 is registered in ClinicalTrials.gov with Rheumazentrum Ruhrgebiet as lead sponsor.

NCT NCT01286545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01286545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
European Ankylosing Spondylitis Infliximab Cohort (EASIC) Follow up Registration Study
Lead sponsor
Rheumazentrum Ruhrgebiet
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2011
Completion date
October 31, 2013
Enrollment
100 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis